{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:27:03Z","timestamp":1788355623446,"version":"build-2803163510"},"reference-count":46,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Ministry of Finance","award":["201711220412052"],"award-info":[{"award-number":["201711220412052"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2026,1,18]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Metformin has been identified as a potential treatment for age-related macular degeneration (AMD). Photographic screening for diabetic retinopathy provides an opportunity to conduct a case-control study with systematic AMD grading. We aimed to investigate associations between metformin use and incidence and progression of AMD at different grades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We randomly sampled 2600 participants from 10\u2009336 people aged \u226550 years with diabetes who attended retinopathy screening in 2011 (baseline) and were enrolled to the Individualised Screening for Diabetic Retinopathy study. 2545 of these participants had type 2 diabetes and gradable fundus photographs at baseline, which were graded using modified age related eye disease study grading. We used data including those on metformin prescription from general practitioner records. We used multivariate logistic regression to investigate associations between metformin and incidence or progression of early, intermediate and late AMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2545 participants, 2089 attended and had gradable fundus images on year 5. Metformin was associated with reduced incidence of intermediate AMD by 5 years after adjusting for confounders (complete record OR 0.63, 95%\u2009CI 0.43 to 0.92, p=0.02). In univariate analysis, metformin was associated with reduced incidence of late AMD (OR 0.43, 95% CI 0.21 to 0.88, p=0.02) but this did not remain significant after adjusting for age and sex. The numbers progressing to late AMD were small. There was no association between metformin and the incidence of early AMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We have found a significant association between metformin use and reduction in incidence of intermediate AMD by 37% in people with diabetes over 5 years. Previous epidemiological studies of metformin and AMD have used secondary data on AMD. In this observational study, there were baseline differences between groups, although significant findings remained after adjusting for important confounders. Given metformin\u2019s anti-ageing therapeutic effects, the reduction in risk is plausible and warrants prospective clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2025-002339","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:15:11Z","timestamp":1770095711000},"page":"e002339","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Metformin and incidence of age-related macular degeneration in people with diabetes: a population-based 5-year case-control study"],"prefix":"10.1136","volume":"11","author":[{"given":"Dewi Fathin","family":"Romdhoniyyah","sequence":"first","affiliation":[{"name":"Eye and Vision Science, University of Liverpool, Liverpool, UK"},{"name":"Department of Ophthalmology, Universitas Gadjah Mada, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesh","family":"Alshukri","sequence":"additional","affiliation":[{"name":"Eye and Vision Science, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Parry","sequence":"additional","affiliation":[{"name":"Liverpool Ophthalmic Reading Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Harding","sequence":"additional","affiliation":[{"name":"Eye and Vision Science, University of Liverpool, Liverpool, UK"},{"name":"St Paul\u2019s Eye Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-990X","authenticated-orcid":false,"given":"Nicholas A V","family":"Beare","sequence":"additional","affiliation":[{"name":"Eye and Vision Science, University of Liverpool, Liverpool, UK"},{"name":"St Paul\u2019s Eye Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026020221150827000_11.1.e002339.1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/aos.15655","article-title":"Association between oral metformin use and the risk of age-related macular degeneration: A systematic review with meta-analysis","volume":"101","author":"Holtz","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40123-021-00344-3","article-title":"Metformin, A Potential Role in Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis","volume":"10","author":"Romdhoniyyah","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"2026020221150827000_11.1.e002339.3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.survophthal.2023.01.007","article-title":"Effects of systemic drugs on the development and progression of age-related macular degeneration","volume":"68","author":"Grimes","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.4","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311258"},{"key":"2026020221150827000_11.1.e002339.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.03.046"},{"key":"2026020221150827000_11.1.e002339.6","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.11.8.10","article-title":"Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Age-Related Macular Degeneration","volume":"11","author":"Nadeem","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"2026020221150827000_11.1.e002339.7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2174\/1573399816666200206112318","article-title":"Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications","volume":"16","author":"Vaughan","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"2026020221150827000_11.1.e002339.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.05.011"},{"key":"2026020221150827000_11.1.e002339.9","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1635361","article-title":"Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats","volume":"2016","author":"Chukwunonso Obi","year":"2016","journal-title":"J Diabetes Res"},{"key":"2026020221150827000_11.1.e002339.10","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12765","article-title":"Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7","volume":"17","author":"Fang","year":"2018","journal-title":"Aging Cell"},{"key":"2026020221150827000_11.1.e002339.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.04.017"},{"key":"2026020221150827000_11.1.e002339.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41393-018-0168-x"},{"key":"2026020221150827000_11.1.e002339.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183506","article-title":"Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis","volume":"12","author":"Ara\u00fajo","year":"2017","journal-title":"PLoS One"},{"key":"2026020221150827000_11.1.e002339.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308445"},{"key":"2026020221150827000_11.1.e002339.15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13655"},{"key":"2026020221150827000_11.1.e002339.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.02.006"},{"key":"2026020221150827000_11.1.e002339.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119708","article-title":"Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1","volume":"10","author":"Joe","year":"2015","journal-title":"PLoS One"},{"key":"2026020221150827000_11.1.e002339.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.01.018"},{"key":"2026020221150827000_11.1.e002339.19","doi-asserted-by":"crossref","first-page":"101240","DOI":"10.1016\/j.arr.2020.101240","article-title":"Recent advances in the field of caloric restriction mimetics and anti-aging molecules","volume":"66","author":"Martel","year":"2021","journal-title":"Ageing Res Rev"},{"key":"2026020221150827000_11.1.e002339.20","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa023"},{"key":"2026020221150827000_11.1.e002339.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100741","article-title":"Potential Efficacy of Metformin for Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis","volume":"5","author":"Huh","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"2026020221150827000_11.1.e002339.22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamaophthalmol.2022.1435","article-title":"Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study","volume":"140","author":"Vergroesen","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025788","article-title":"Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening","volume":"9","author":"Broadbent","year":"2019","journal-title":"BMJ Open"},{"key":"2026020221150827000_11.1.e002339.24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/dom.13552","article-title":"Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules","volume":"21","author":"Garc\u00eda-Fi\u00f1ana","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2026020221150827000_11.1.e002339.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"2026020221150827000_11.1.e002339.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01055-2"},{"key":"2026020221150827000_11.1.e002339.27","unstructured":"Romdhoniyyah DF , Beare NAV . Age-related macular degeneration in people with diabetes mellitus: prevalence, incidence, and determinants. Research Data Catalogue. University of Liverpool, 2023."},{"key":"2026020221150827000_11.1.e002339.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01218-1"},{"key":"2026020221150827000_11.1.e002339.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"2026020221150827000_11.1.e002339.30","first-page":"127","article-title":"Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior","volume":"86","author":"Cicchetti","year":"1981","journal-title":"Am J Ment Defic"},{"key":"2026020221150827000_11.1.e002339.31","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1649156","article-title":"Association between Metformin and a Lower Risk of Age-Related Macular Degeneration in Patients with Type 2 Diabetes","volume":"2019","author":"Chen","year":"2019","journal-title":"J Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.32","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.65.3.23","article-title":"The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy","volume":"65","author":"Moir","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026020221150827000_11.1.e002339.33","doi-asserted-by":"publisher","DOI":"10.1177\/1120672121997288"},{"key":"2026020221150827000_11.1.e002339.34","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.64.11.22","article-title":"Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study","volume":"64","author":"Kaufmann","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026020221150827000_11.1.e002339.35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamaophthalmol.2020.6331","article-title":"Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study","volume":"139","author":"Blitzer","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/IAE.0000000000003968","article-title":"ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT","volume":"44","author":"Khanna","year":"2024","journal-title":"Retina"},{"key":"2026020221150827000_11.1.e002339.37","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-26422"},{"key":"2026020221150827000_11.1.e002339.38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1275095","article-title":"Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study","volume":"14","author":"Huang","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026020221150827000_11.1.e002339.39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jamaophthalmol.2023.5478","article-title":"Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes","volume":"142","author":"Aggarwal","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.40","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319641"},{"key":"2026020221150827000_11.1.e002339.41","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.11.1484"},{"key":"2026020221150827000_11.1.e002339.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802724115"},{"key":"2026020221150827000_11.1.e002339.43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00417-019-04548-z","article-title":"Metformin and rapamycin protect cells from vital dye-induced damage in retinal pigment epithelial cells and in vivo","volume":"258","author":"Shu","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.44","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.453","article-title":"Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration","volume":"8","author":"Golestaneh","year":"2017","journal-title":"Cell Death Dis"},{"key":"2026020221150827000_11.1.e002339.45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/aos.13772","article-title":"The role of autophagy in age-related macular degeneration (AMD) - studies into the pathogenesis of AMD","volume":"96","author":"Kivinen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"2026020221150827000_11.1.e002339.46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100440","article-title":"METformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial","volume":"4","author":"Shen","year":"2024","journal-title":"Ophthalmol Sci"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2025-002339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:15:15Z","timestamp":1770095715000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2025-002339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjophth-2025-002339"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2025-002339","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}